Business Description
Intercure Ltd
ISIN : IL0011063760
Total Employee Number:
285Description
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | -7.49 | |||||
Interest Coverage | 0.34 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.14 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.3 | |||||
3-Year FCF Growth Rate | -29.1 | |||||
3-Year Book Growth Rate | -13 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.22 | |||||
9-Day RSI | 48.6 | |||||
14-Day RSI | 50.19 | |||||
3-1 Month Momentum % | 15 | |||||
6-1 Month Momentum % | -6.98 | |||||
12-1 Month Momentum % | -43.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.48 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 198.57 | |||||
Days Sales Outstanding | 54.01 | |||||
Days Payable | 121.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -0.97 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 12.28 | |||||
Operating Margin % | 2.49 | |||||
Net Margin % | -13.22 | |||||
EBITDA Margin % | -9.05 | |||||
FCF Margin % | 4.92 | |||||
OCF Margin % | 6.23 | |||||
ROE % | -8.75 | |||||
ROA % | -4.86 | |||||
ROIC % | 1.01 | |||||
3-Year ROIIC % | 72.77 | |||||
ROC (Joel Greenblatt) % | -16.85 | |||||
ROCE % | -4.69 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 2.07 | |||||
PS Ratio | 0.59 | |||||
PB Ratio | 0.41 | |||||
Price-to-Tangible-Book | 0.93 | |||||
Price-to-Free-Cash-Flow | 12.09 | |||||
Price-to-Operating-Cash-Flow | 9.53 | |||||
EV-to-EBIT | -12.6 | |||||
EV-to-EBITDA | -12.6 | |||||
EV-to-Forward-EBITDA | 10.47 | |||||
EV-to-Revenue | 1.14 | |||||
EV-to-Forward-Revenue | 0.76 | |||||
EV-to-FCF | 23.17 | |||||
Price-to-GF-Value | 0.78 | |||||
Price-to-Projected-FCF | 2.54 | |||||
| Price-to-Net-Current-Asset-Value | 7.07 | |||||
Earnings Yield (Greenblatt) % | -7.94 | |||||
FCF Yield % | 7.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intercure Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 89.686 | ||
| EPS (TTM) ($) | -0.219 | ||
| Beta | 1.5639 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 61.67 | ||
| 14-Day RSI | 50.19 | ||
| 14-Day ATR ($) | 0.064775 | ||
| 20-Day SMA ($) | 1.01079 | ||
| 12-1 Month Momentum % | -43.61 | ||
| 52-Week Range ($) | 0.68 - 1.7698 | ||
| Shares Outstanding (Mil) | 57.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Intercure Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Intercure Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-30 16:00 | In 169 days | ||
| Second quarter earnings results for 2026 | 2026-10-08 | In 85 days | ||
| Annual report for 2025 | 2026-05-01 | 0.84 (+0.66%) | ||
| Fourth quarter earnings results for 2025 | 2026-05-01 | 0.84 (+0.66%) | ||
| General meeting for 2025 | 2025-12-30 16:00 | 1.06 (-5.36%) | ||
| Second quarter earnings results for 2025 | 2025-10-08 | 1.62 (+1.57%) | ||
| Annual report for 2024 | 2025-05-01 | 1.57 (+5.28%) | ||
| Fourth quarter earnings results for 2024 | 2025-05-01 | 1.57 (+5.28%) | ||
| General meeting for 2024 | 2024-12-30 16:00 | 1.63 (-3.78%) | ||
| Second quarter earnings results for 2024 | 2024-08-29 | 2.26 (+2.73%) |
Show
Entries
Intercure Ltd Frequently Asked Questions
What is Intercure Ltd(INCR)'s stock price today?
The current price of INCR is $0.99. The 52 week high of INCR is $1.77 and 52 week low is $0.68.
When is next earnings date of Intercure Ltd(INCR)?
The next earnings date of Intercure Ltd(INCR) is 2026-10-08 Est..
Does Intercure Ltd(INCR) pay dividends? If so, how much?
Intercure Ltd(INCR) does not pay dividend.
Guru Commentaries on NAS:INCR
No articles.
Press Release
Articles on Intercure Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers